Caption Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Caption Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25,000	Closed	-$244K	–	2070
2021 Q4	$244K	Sell	25,000 -603	-2%	-$11.3K	﹤0.01%	1390
2021 Q3	$870K	Sell	25,603 -6,897	-21%	-$220K	0.01%	1058
2021 Q2	$1.19M	Buy	32,500 +21,400	+193%	+$829K	0.02%	839
2021 Q1	$498K	Buy	+11,100	New	+$517K	0.01%	807
2020 Q1	–	Sell	-39,900	Closed	-$2.22M	–	1135
2019 Q4	$2.48M	Buy	+39,900	New	+$1.9M	0.08%	318

Other funds holding DCPH

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Caption Management's DCPH Position: Q1 2022 in Review

Caption Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2022, closing a stake of 25,000 shares — an estimated $244K sold.

Caption Management first reported a position in DCPH in Q4 2019 and held it in 5 quarters. The position peaked at $2.48M in Q4 2019. 123 funds tracked by Wall St. Rank hold DCPH as of Q1 2022.

Caption Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Caption Management sold 25,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $244K.
Caption Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Caption Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.48M in Q4 2019.
123 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Caption Management's 13F filing for Q1 2022, filed 13 May 2022.